Standout Papers

<i>TET2</i>-Driven Clonal Hematopoiesis and Response to Canakinumab 2022 2026 2023 2024195
  1. TET2-Driven Clonal Hematopoiesis and Response to Canakinumab (2022)
    E. C. Svensson, Aviv Madar et al. JAMA Cardiology

Immediate Impact

3 by Nobel laureates 8 from Science/Nature 58 standout
Sub-graph 1 of 21

Citing Papers

Frailty in Older Adults
2024 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
2 intermediate papers

Works of Michael T. Beste being referenced

TET2-Driven Clonal Hematopoiesis and Response to Canakinumab
2022 Standout
Inhibition of IL1β by Canakinumab May Be Effective against Diverse Molecular Subtypes of Lung Cancer: An Exploratory Analysis of the CANTOS Trial
2020

Author Peers

Author Last Decade Papers Cites
Michael T. Beste 348 253 193 209 24 979
Markus M. Valter 510 134 82 335 25 1.1k
Stefania Marzinotto 178 81 114 428 44 1.0k
Rick Kamps 217 219 136 475 25 1.0k
Heather J. Dalton 244 153 50 420 29 971
Sarah Wilkinson 344 90 40 360 27 903
Karin Kunzi‐Rapp 152 119 135 290 24 828
Masahiro Sato 165 44 69 735 24 1.0k
Sarah Chambers 94 88 195 245 36 791
Anthony J. Apicelli 145 33 55 501 26 994
Karen D. Cowden Dahl 135 100 120 670 25 1.1k

All Works

Loading papers...

Rankless by CCL
2026